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Abstract
In pregnant women there is a twofold increase in iron requirements due to increased blood volume without the 
expansion of plasma volume. Pregnant women are very prone to suffering from iron deficiency anemia. Iron 
deficiency anemia generally has an erythrocyte index which represents  hypochromic microcytic. This study aimed 
to determine the effect of three-month iron tablet supplementation as a therapy against microcytic hypochromic 
anemia in pregnancy. This was a quantitative quasi-experimental study using pre-test and post-test design. The 
study was conducted in May-September 2020 at the Arifin Achmad Regional General Hospital, Riau Province, 
Indonesia. Subjects were 30 pregnant women with microcytic hypochromic anemia. Primary data were analyzed 
using statistical paired sample t-tests. Results showed that there was an increase in hemoglobin levels after the 
supplementation of iron tablet from an average of 9.1±1.2 gr/dL to 11.8±1.0 g/dL. This change was significant 
based on the results of the T-test (p-0.003) Thus, iron supplementation for three month significantly increases 
hemoglobin levels in pregnant women.
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Suplementasi Zat Besi Selama 3 Bulan sebagai Tatalaksana Anemia 
Mikrositik Hipokrom Dalam Kehamilan
Abstrak 
Pada ibu hamil terjadi peningkatan kebutuhan  zat  besi dua kali  lipat akibat peningkatan volume darah tanpa 
ekspansi volume plasma. Ibu hamil sangat rentan untuk menderita anemia defisiensi besi. Anemia defisisensi besi 
umumnya memiliki gambaran indeks eritrosit sebagai mikrositik hipokrom. Penelitian ini bertujuan mengetahui 
efek suplementasi tablet besi selama tiga bulan sebagai terapi terhadap anemia mikrositik hipokrom dalam 
kehamilan. Jenis penelitian yang digunakan yaitu penelitian kuantitatif, dengan desain penelitian quasi eksperimen 
jenis one group pre-test dan post-test. Penelitian dilakukan pada bulan Mei–September 2020 di Rumah Sakit 
Umum Daerah Arifin Achmad Provinsi Riau. Subjek penelitian ini adalah 30 ibu hamil dengan anemia mikrositik 
hipokrom. Dilakukan analisis pada data primer dengan menggunakan uji statistik paired sample t-test. Hasil 
penelitian menunjukkan kenaikan rata-rata kadar hemoglobin dari sebelum pemberian suplementasi zat besi, 
yaitu 9,1±1,2 gr/dL menjadi 11,8±1,0 gr/dL (sesudah pemberian tablet besi). Perubahan ini signifikan berdasar 
atas hasil uji-t (p=0,003). Simpulan, suplementasi zat besi selama tiga bulan secara signifikan meningkatkan 
kadar hemoglobin pada ibu hamil.
Kata kunci: Anemia mikrositik hipokrom, kehamilan, tablet besi
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Introduction
Pregnant women are one of the groups prone 
to malnutrition, because there is an increase 
in nutritional needs to meet the needs of the 
mother and the fetus. One of the most common 
nutritional problems in pregnant women is 
nutritional anemia, which is the biggest and most 
difficult micro-nutrition problem to overcome 
in the world.1,2 The World Health Organization 
(WHO) reports that 52% of pregnant women 
experience anemia in developing countries. In 
Indonesia (Susenas and the Ministry of Health-
Unicef Survey) it is reported that of about 4 
million pregnant women, half have nutritional 
anemia and one million experience chronic 
energy deficiency.3
A report by United States Agency for 
International Development (USAID), 
Micronutrient and Child Blindness Project, 
and Food and Nutrition Technical Assistance 
shows that about 50% of all types of anemia 
are thought to result from iron deficiency. Iron 
deficiency anemia often occurs as a result of 
pregnant women with a twofold increase in iron 
demand due to increased blood volume without 
expansion of plasma volume, to meet maternal 
needs (to prevent blood loss during childbirth) 
and fetal growth. Iron deficiency anemia is 
manifested on the erythrocyte index in the form 
of microcytic hypochromic anemia. 4
There is a close correlation between anemia 
during pregnancy with fetal death, abortion, 
congenital defects, low birth weight, reduced 
iron stores in children or children born with 
nutritional anemia. This condition causes the 
perinatal mortality rate to remain high, as well as 
maternal mortality and morbidity. In addition, it 
can worsen and cause bleeding during childbirth 
which is the main cause (28%) of maternal 
mortality/childbirth in Indonesia. Anemia in 
pregnancy is linked to post partum hemorrhage 
in terms of uterine atony. Decreased uterine 
blood flow or low uterine muscle strength may 
contribute to inefficient uterine contractility 
(uterine atony).5 Therefore, researchers are 
interested in conducting research on the effect of 
giving iron tablets for three months as a therapy 
for microcytic hypochromic anemia in pregnant 
women at the Arifin Achmad Regional General 
Hospital, Riau province in order to reduce 
complication of anemia on maternal and fetal 
mortality and morbidity.
Methods
The research was conducted from May 2020 to 
September 2020 at the Midwifery Polyclinic of 
the Arifin Achmad Regional General Hospital, 
Pekanbaru, Riau Province. Determination of 
the sample size was taken using the Slovin 
technique, as many as 30 samples. The type 
of sample in this study is purposive sampling. 
Purposive Sampling is a sampling technique with 
certain considerations or special selection. The 
inclusion criteria were pregnant women with 
hypochromic microcytic anemia. Meanwhile, the 
exclusion criteria were pregnant women with 
congenital blood disorders and kidney disorders; 
and pregnant women with acute bleeding.
For pregnant women, the hemoglobin levels 
and levels of mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), and 
mean corpuscular hemoglobin concentration 
(MCHC) were checked to find pregnant women 
with hypochromic microcytic anemia. The above 
pregnant women are classified as samples. The 
research sample will then be given iron tablets 
for 3 months (90 iron tablets). At the second visit 
to the field (3 months later), the anemia status 
will be re-evaluated by checking the hemoglobin 
levels in pregnant women.
The data collected is primary data obtained 
directly using a hematological measuring 
device, Sysmex XN-1000 year 2019, namely 
the difference in hemoglobin levels before and 
after consuming Fe tablets in pregnant women. 
Data in the form of numbers before and after 
consuming Fe tablets, are presented in the form 
of a descriptive table. Data analysis was carried 
out to see the relationship between Fe tablets 
and anemia improvement in pregnant women 
at the Arifin Achmad Regional General Hospital, 
Riau Province.
This type of quantitative research, one group 
pretest-posttest design. The population was all 
pregnant women, namely 102 pregnant women 
who checked their pregnancies at the Regional 
General Hospital Arifin Achmad, Riau Province 
from May to September 2020. The research 
sample was 30 taken by purposive sampling 
technique. Data analysis using statistical 
test T dependent sample. This research was 
conducted after passing the Ethical Study of the 
Faculty of Medicine, Riau University No: B/137/
UN19.5.1.1.8/UEPKK/2020.
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Results
This study attempted to analyze the sample 
characteristic data of a total of 30 patients with 
anemia in this study. Data analysis was carried 
out based on age group, education level, number 
of parity and gap between pregnancies. From the 
results of data analysis as shown in Table 1, it 
is found that low education does not guarantee 
a pregnant woman suffers from anemia, the 
highest incidence of anemia is found in patients 
with middLe level of education, which is then 
followed by a high level of education. Based on 
age, it was also found that younger group of 
pregnant woman and older group of pregnant 
woman also did not make up the majority of 
pregnant women with anemia. It was found that 
women in the middLe age were the majority of 
pregnant women who suffered from anemia.
Women with more than one parity 
(multigravida) appear to belong to the group of 
pregnant women who experience anemia more 
than primigravda women. And a pregnancy 
interval of more than 2 years in pregnant women 
appears to have anemia more than the women 
Table 1 Sample Characteristic
Parameter (n=30)
Education 
Bellow high school/ equal 7 
High school/ equal 15








Pregnancy gap on multigravida
<2 years 7 
>2 years 20 
Table 2 Comparison of Hb Levels Before and 








whose pregnancy that less than two years.
This study analyzed the effects of iron 
supplementation before and after iron 
supplementation in this study groups. From the 
observation analysis, it was found that there 
was a significant increase in Hb levels after iron 
supplementation (p=0.003) as shown in Table 2.
Discussion
From Table 2, it can be seen that the average 
hemoglobin level in pregnant women with 
anemia before giving iron (Fe) tablets is 9.1±1.2, 
while after giving iron tablets (Fe) the average 
hemoglobin levels of anemic pregnant women 
are 11.8±1.0. Based on statistical analysis with 
the t test, it can be concluded that giving iron 
tablets before and after anemic pregnant women 
affects hemoglobin levels with a p.value of 0.003, 
this value is <(0.05).
Based on the sample examination, it was 
found that the average hemoglobin level in 
pregnant women before giving iron (Fe) tablets 
was 9.1 g/dL and the hemoglobin level after 
giving iron (Fe) tablets was 11.8 g/dL. These 
results indicate an increase in hemoglobin levels 
in pregnant women after consuming iron (Fe) 
tablets of 2.7 g/dL. Age does not affect the low 
levels of hemoglobin in pregnant women who 
are anemic. Low hemoglobin levels in pregnant 
women are influenced by the lack of consumption 
of foods containing iron and high consumption of 
substances that can suppress iron absorption.6
The results of this study are in line with 
research conducted by Fanny at the Tamamaung 
Health Center in 2011. This study also showed the 
same outcome as Ratih, there was an increase in 
hemoglobin by an average of 3.7 g/dL in anemic 
pregnant women with iron supplementation.7
Until now, iron supplementation is an effort to 
increase hemoglobin levels in pregnant women 
who are prone to suffering from anemia. For the 
dose of supplementation, according to research 
conducted by Vazquez et al.,8 It was found that 
iron supplementation at a dose of 40–80 mg per 
day (with an average of 60 mg) had a much better 
outcome compared to supplementation of 20–40 
mg per day without any adverse side effects for 
both mother and fetus.
Research by Abu Ouf et al.6 and Arija et al.9 on 
pregnant women with anemia who were given 
iron tablet supplementation for 1–3 months also 
showed the same outcome as this study. The 
output obtained was an increase in maternal 
hemoglobin levels and a better outcome in 
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infants. This study also shows that all pregnant 
women are prone to anemia. Both those who 
have a normal body mass index or obesity also 
have the same risk of suffering from anemia. 
Thus, iron supplementation must be encouraged 
for all groups of pregnant women.10
According to the Dietary Reference Intake, 
the need for iron in pregnant women increases 
from 18 mg/day in adult women to 27 mg/day 
in pregnant women. World Health Organization 
(WHO) recommends that every pregnant woman 
consume Fe supplement 60 mg per day for 6 
months. Providing iron supplements, namely 60 
mg  day preparations can increase hemoglobin 
levels by 1 g%/month.11 This theory is in 
accordance with the results of research which 
shows an average increase in hemoglobin 2.8 g/
dL in the sample for 3 months.
The weakness of this study is that it does not 
do direct monitoring of medication adherence 
and does not check ferritin levels before and 
after iron tablet therapy. We need larger sample 
and better monitoring in the future. This study 
revealed excellent hemoglobin responses to 
iron supplementation in the study participants. 
These results indicate an increase in hemoglobin 
levels in pregnant women after consuming iron 
(Fe) tablets of 2.7 g/dL in average.
In conclusion, this study showed that three 
months iron supplementation improved the 
hemologlobin level of microcytic hypochromic 
anemia in pregnancy. 
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